MAYNE PHARMA LTD ORDINARY (MYX) Short Interest
MAYNE PHARMA LTD ORDINARY (ASX:MYX) had 2.98% of shares reported as short positions as of 16 May 2026, representing 2,421,451 shares. MAYNE PHARMA LTD ORDINARY operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
- Short interest
- 2.98%
- Reported positions
- 2,421,451
- Industry
- Pharmaceuticals, Biotechnology & Life Sciences
- As of
- 16 May 2026
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
MYX
Mayne Pharma Group
Mayne Pharma Group Limited is a specialty pharmaceutical company listed on the ASX, focused on commercializing pharmaceuticals and improving patient access to life-enhancing medications. The company has a 40-year track record of innovation in developing oral drug delivery systems, offering a portfolio of branded and generic drugs in therapeutic areas like women's health and dermatology.